Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

October 01, 1992; Volume 263,Issue 1
  • You have access
    Nicotinic receptor-evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels.
    T Takahashi, Y Tsunoda, Y Lu, J Wiley and C Owyang
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 1-5;
  • You have access
    Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
    D de Cheffoy de Courcelles, K de Loore, E Freyne and P A Janssen
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 6-14;
  • You have access
    Membrane potential in myenteric neurons associated with tolerance and dependence to morphine.
    J A Leedham, J Q Kong, D A Taylor, S M Johnson and W W Fleming
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 15-19;
  • You have access
    Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
    A N Schoffelmeer, T J De Vries, F Hogenboom, V J Hruby, P S Portoghese and A H Mulder
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 20-24;
  • You have access
    A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
    A Yamamoto, E Hayakawa, Y Kato, A Nishiura and V H Lee
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 25-31;
  • You have access
    Effects of intrauterine position on the hepatic microsomal polysubstrate monooxygenase and cytosolic glutathione S-transferase activity, plasma sex steroids and relative organ weights in adult male and female Long-Evans rats.
    T van der Hoeven, R Lefevre and R Mankes
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 32-39;
  • You have access
    Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
    Z H Zhang, C H Follmer, J S Sarma, F Chen and B N Singh
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 40-48;
  • You have access
    Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins.
    J J Choi, G J Huang, E Shafik, W H Wu and J J McArdle
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 49-53;
  • You have access
    Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia.
    S J Henderson and W E Lindup
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 54-60;
  • You have access
    Release of endogenous norepinephrine from rat hypothalamus by stimulation of N-methyl-D-aspartic acid receptors.
    P Blandina, D Johnson, J Walcott and J Goldfarb
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 61-68;
  • You have access
    Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
    D Fau, A Berson, D Eugene, B Fromenty, C Fisch and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 69-77;
  • You have access
    Flavonoid potentiation of contractile responses in rat blood vessels.
    M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;
  • You have access
    Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.
    M K James, A Vuong, M K Grizzle, S V Schuster and J E Shaffer
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 84-91;
  • You have access
    Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;
  • You have access
    Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.
    D E Selley and J M Bidlack
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 99-104;
  • You have access
    Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs.
    J H Lin, I W Chen and J King
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 105-111;
  • You have access
    A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin.
    T Godfraind, C Dessy and S Salomone
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 112-122;
  • You have access
    Serotonin-induced relaxation in canine coronary artery smooth muscle.
    D J Cushing and M L Cohen
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 123-129;
  • You have access
    Pulmonary accumulation of propranolol in vivo: sites and physiochemical mechanism.
    R E Howell and P N Lanken
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 130-135;
  • You have access
    Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat.
    A B Malmberg and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 136-146;
  • You have access
    Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
    F Porreca, A E Takemori, M Sultana, P S Portoghese, W D Bowen and H I Mosberg
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 147-152;
  • You have access
    Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose.
    B Tesfamariam, M L Brown and R A Cohen
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 153-157;
  • You have access
    Enhanced blood pressure and renal hemodynamic effect of chronic versus acute lisinopril administration in the rabbit.
    A F Hajj-Ali and B G Zimmerman
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 158-162;
  • You have access
    Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.
    G D Pennock, T E Raya, J J Bahl, S Goldman and E Morkin
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 163-169;
  • You have access
    Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
    N Marczin, U S Ryan and J D Catravas
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 170-179;
  • You have access
    The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
    B K Yamamoto and H Y Meltzer
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 180-185;
  • You have access
    Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
    J S Strobl and V A Peterson
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 186-193;
  • You have access
    On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea.
    M Iguchi, T Nakajima, T Hisada, T Sugimoto and Y Kurachi
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 194-200;
  • You have access
    Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.
    H Yazawa, M Takanashi, K Sudoh, O Inagaki and K Honda
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 201-206;
  • You have access
    Block of voltage-gated potassium currents by anticonvulsant U-54494A in mouse neuroblastoma cells.
    Y Zhu, H K Im and W B Im
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 207-213;
  • You have access
    Selective inhibitory effects of calcium channel antagonists on the two components of the neurogenic response of guinea pig vas deferens.
    F Hata, A Fujita, K Saeki, I Kishi, T Takeuchi and O Yagasaki
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 214-220;
  • You have access
    Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.
    M T Griffin and F J Ehlert
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 221-225;
  • You have access
    Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
    P Kostka, S Ahmad, C Y Kwan, E E Daniel, R K Gordon and P K Chiang
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 226-231;
  • You have access
    Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice.
    N C De Fiebre, R J Marley, J M Wehner and A C Collins
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 232-240;
  • You have access
    Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells.
    S Oda, T Sano, Y Morishita and Y Matsuda
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 241-245;
  • You have access
    Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
    J Y Xu, J M Fujimoto and L F Tseng
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 246-252;
  • You have access
    Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
    M F Jarvis, G W Gessner, G E Martin, M Jaye, M W Ravera and C A Dionne
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 253-263;
  • You have access
    Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
    A B Malmberg and T L Yaksh
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 264-275;
  • You have access
    The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    E M Hoenicke, S A Vanecek and J H Woods
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 276-284;
  • You have access
    Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor.
    S W Kerr, L V Buchanan, S Bunting and W R Mathews
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 285-292;
  • You have access
    Gentamicin-induced hypercalciuria in the rat: assessment of nephron site involved.
    H O Garland, D J Phipps and E S Harpur
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 293-297;
  • You have access
    Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
    G Perrault, E Morel, D J Sanger and B Zivkovic
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 298-303;
  • You have access
    S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
    M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;
  • You have access
    Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
    T W Moody, J Staley, F Zia, D H Coy and R T Jensen
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 311-317;
  • You have access
    Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
    C W Callaway and M A Geyer
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 318-326;
  • You have access
    N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation.
    A Pittaluga and M Raiteri
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 327-333;
  • You have access
    In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase.
    Z Hu and P G Wells
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 334-342;
  • You have access
    Chronic cocaine treatment suppresses basal expression of zif268 in rat forebrain: in situ hybridization studies.
    R V Bhat, A J Cole and J M Baraban
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 343-349;
  • You have access
    Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells.
    S G Beck, K C Choi and T J List
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 350-359;
  • You have access
    Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.
    J S Leeder, R J Riley, V A Cook and S P Spielberg
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 360-367;
  • You have access
    Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis.
    X Z Ding and I Mocchetti
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 368-373;
  • You have access
    Gastroprotective effects of thromboxane receptor antagonists.
    M L Ogletree, E H O'Keefe, S K Durham, B Rubin and G Aberg
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 374-380;
  • You have access
    Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
    H Sakai, T Okamoto and Y Kikkawa
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 381-386;
  • You have access
    Ca(++)-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: effects of Ca(++)-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice.
    S D Ray, C L Sorge, L M Kamendulis and G B Corcoran
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 387-394;
  • You have access
    The role of adrenergic receptors in the initiation of vomiting and its gastrointestinal motor correlates.
    I M Lang and S K Sarna
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 395-403;
  • You have access
    Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture.
    C R Albrightson, P Nambi, B Zabko-Potapovich, G Dytko and T Groom
    Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 404-412;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 263, Issue 1
1 Oct 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Nose-to-Brain Delivery
  • Interaction between Bupropion and MDMA
  • Smoking Could Worsen COVID-19 Outcome
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics